PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Paul Rennie interviewed on Marcus Today Podcast., page-42

  1. 4,213 Posts.
    lightbulb Created with Sketch. 6693
    Hamman, agreed, there is a lot of risk particularly with the spine...its a non brainer to at least try out Zylosul, if no effect then fine, the patients can think about the next step.

    With some 88% of SAS getting some pain relief, it certainly is a wonderful first step to try.

    Yes TGA application will be great news when it eventuates...it will take some time on the assumption we get the green light, but it will be another excellent pathway for the beginning of that first time revenue kicking off in the not too distant future.



    Multiply the TGA program by a factor of 15 + in terms of any possible AA program.
    A number of steps to still line up for this but we are getting there in my view.





 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.